Related Experiment Video
Updated: Dec 19, 2025

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Improved Activity of Rifampicin Against Biofilms of Staphylococcus aureus by Multicomponent Complexation
Antonella V Dan Córdoba1, Virginia Aiassa1, Marcela R Longhi1
1Unidad de Investigación y Desarrollo en Tecnología Farmacéutica, UNITEFA-CONICET, Facultad de Ciencias Químicas, Departamento de Ciencias Farmacéuticas, Universidad Nacional de Córdoba, Haya de la Torre y Medina Allende, s/n. Ciudad Universitaria, X5000HUA, Córdoba, Argentina.
Abstract:
The aim of this study was to evaluate a multicomponent complex (MC) between rifampicin (RIF), β-cyclodextrin (β-CD), and selected amino acids to enhance the solubility and antibiofilm activity of RIF. After performing phase-solubility studies that demonstrated a considerable increase in the solubility of RIF for the MC, the corresponding solid system was prepared by a freeze-drying method. Characterization of the MC was performed by Fourier transform-infrared spectroscopy, thermal analysis, powder X-ray diffraction, and scanning electron microscopy. Structural analyses evidenced molecular interactions between the components, resulting in a MC with amorphous solid features. Structural studies involving both experimental (i.e., 1H NMR) and theoretical (i.e., molecular modeling) methodologies demonstrated the inclusion of the RIF piperazine ring in the β-CD cavity. The bioactivity of the MC measured against biofilms of Staphylococcus aureus showed a significant reduction in the metabolic activity of the bacterium. Overall, the studied MC exhibited promising properties for the development of pharmaceutical formulations to treat bacterial infections.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Biofilms
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Antimicrobial Effectiveness

